Your browser doesn't support javascript.
loading
A standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancer.
Zhu, Zhihua; Mei, Weijian; Song, Zhengbo; Jiao, Wenjie; Huang, Qinghua; Zhu, Lianxin; An, Chaolun; Shi, Jianguang; Wang, Wenxian; Yu, Guiping; Sun, Pingli; Zhang, Yinbin; Shen, Jianfei; Song, Yong; Gilbert, Sebastien; Ruetzler, Kurt; Villamizar, Nestor R; Xu, Chunwei; Qian, Jun; Yao, Wang; Yang, Han.
Afiliação
  • Zhu Z; Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Mei W; Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Song Z; Department of Medical Oncology, Cancer Hospital of University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
  • Jiao W; Department of Thoracic Surgery, Affiliated Hospital of Qingdao University, Qingdao, China.
  • Huang Q; Department of Breast Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.
  • Zhu L; Medical College of Nanchang University, Nanchang, China.
  • An C; Department of Clinic Medicine, School of Queen Mary, Nanchang University, Nanchang, China.
  • Shi J; Department of Thoracic Surgery, Nantong Third People's Hospital Nantong University, Nantong, China.
  • Wang W; Department of Thoracic Surgery, Ningbo First Hospital of Zhejiang University, Ningbo, China.
  • Yu G; Department of Medical Oncology, Cancer Hospital of University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.
  • Sun P; Department of Thoracic Surgery, Affiliated Jiangyin Hospital of Southeast University, Jiangyin, China.
  • Zhang Y; Department of Pathology, The Second Hospital of Jilin University, Changchun, China.
  • Shen J; Department of Thoracic Surgery, The Second Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, China.
  • Song Y; Department of Thoracic Surgery, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Taizhou, China.
  • Gilbert S; Department of Respiratory Medicine,, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
  • Ruetzler K; Division of Thoracic Surgery, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
  • Villamizar NR; Departments of Outcomes Research and General Anesthesia, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Xu C; Section of Thoracic Surgery, Department of Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA.
  • Qian J; Department of Respiratory Medicine,, Affiliated Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
  • Yao W; Department of Statistics, Southern Medical University, Guangzhou, China.
  • Yang H; Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Transl Lung Cancer Res ; 10(12): 4587-4599, 2021 Dec.
Article em En | MEDLINE | ID: mdl-35070763
ABSTRACT

BACKGROUND:

There is considerable variation in the staging of lymph nodes (LNs) as part of tumor, node, metastasis (TNM) staging of non-small cell lung cancer (NSCLC). A new dissection and pathological examination standard for hilar and intrapulmonary LNs needs to be established for patients with early-stage T1-3N0M0 NSCLC.

METHODS:

This study involved 3,002 patients with T1-3N0M0 NSCLC who underwent radical lobectomy or total pneumonectomy in the thoracic departments of 11 Chinese institutions between January 1999 and October 2013. The Cox model was applied for univariate and multivariate analyses in the examination of station 10, 11 LN and station 12, 13, 14 LN. A hilar and intrapulmonary standard (HI standard) was then established based on univariate and multiple-factor analyses conducted using the Cox model.

RESULTS:

Among the 3,002 patients enrolled in the study, 2,609 underwent at least one examination of station 10, 11 LN (A1), while 393 did not undergo examination of station 10, 11 LN (A0). The A0 and A1 groups had 5-year survival rates of 76% and 80%, respectively (P=0.018). Further, 1,764 patients underwent at least one examination of station 12, 13, 14 LN (B1), while 1,238 patients did not (B0). The B0 and B1 groups had 5-year survival rates of 77% and 82%, respectively (P=0.008). In total, 1,269 patients attained the HI standard (C1), and 1,733 did not (C0). The C0 and C1 groups had 5-year survival rates of 77% and 83%, respectively (P<0.001).

CONCLUSIONS:

The HI standard can improve both the prognosis and survival rates of patients with T1-3N0M0 NSCLC. This will provide important guidance for pulmonary LN dissection and pathological examination in NSCLC cases.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article